Focus on air pollutant components as possible link to cardiovascular disease
The Lovelace Biomedical and Environmental Research Institute will conduct research to develop novel and more specific markers for acute exposure to humans. The Institute's research team will be headed by
Project activities involved in this research will include identifying susceptible individuals, classifying causal components of the complex air pollution mixture, and developing a better understanding of the biological mechanisms involved in air pollution-induced cardiovascular toxicity. As a result of data collected from this study, LRRI hopes to identify individuals who could be at risk of developing atherosclerosis, a chronic arterial inflammatory disease which may lead to heart attacks or stroke.
About Lovelace Respiratory Research Institute
The Lovelace Respiratory Research Institute (LRRI) is a private, biomedical research organization dedicated to improving public health through research on the prevention, treatment and cure of respiratory disease. Since 1947, LRRI is committed to curing respiratory diseases through research aimed at understanding their causes and biological mechanisms; assessing and eliminating exposures to respiratory health hazards; and developing improved therapeutics, vaccines, and diagnostics. LRRI is based in
Contact: Sandy McKay, LRRI, smckay@LRRI.org-505-348-9486 Kyla Thompson, PR, email@example.com
SOURCE Lovelace Respiratory Research Institute